Alemtuzumab as first- and second-line treatment in patients with Sézary syndrome-The experience of a tertiary centre

MeSH terms

• Alemtuzumab* / therapeutic use
• Antibodies, Monoclonal / therapeutic use
• Antineoplastic Agents* / therapeutic use
• Humans
• Sezary Syndrome* / drug therapy
• Skin Neoplasms* / chemically induced
• Skin Neoplasms* / drug therapy
• Treatment Outcome